These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6385738)

  • 21. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro.
    Teklehaimanot A; Nguyen-Dinh P; Collins WE; Barber AM; Campbell CC
    Am J Trop Med Hyg; 1985 May; 34(3):429-34. PubMed ID: 3890574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs.
    Ang HH; Lam CK; Wah MJ
    Chemotherapy; 1996; 42(5):318-23. PubMed ID: 8874969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
    Reynolds MG; Roos DS
    J Biol Chem; 1998 Feb; 273(6):3461-9. PubMed ID: 9452469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of the naphthoquinone derivative menoctone and dihydrofolate reductase inhibitors on Plasmodium falciparum in vitro.
    Percy M; Howells RE
    Ann Trop Med Parasitol; 1986 Jun; 80(3):359-60. PubMed ID: 3541810
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
    Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
    Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activity in vitro of cycloguanil and pyrimethamine in combination against Plasmodium falciparum.
    Yeo AE; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1992; 86(3):234. PubMed ID: 1412640
    [No Abstract]   [Full Text] [Related]  

  • 27. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
    Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
    Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].
    Pinheiro L; Rosário VE
    Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture.
    Ang HH; Cheang HS; Mak JW
    Chemotherapy; 2005 Oct; 51(6):377-80. PubMed ID: 16227695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique.
    Ang HH; Chan KL; Mak JW
    J Parasitol; 1996 Dec; 82(6):1029-31. PubMed ID: 8973418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum.
    Childs GE; Lambros C
    Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
    Canfield CJ; Milhous WK; Ager AL; Rossan RN; Sweeney TR; Lewis NJ; Jacobus DP
    Am J Trop Med Hyg; 1993 Jul; 49(1):121-6. PubMed ID: 8352384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
    J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
    Fidock DA; Wellems TE
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
    Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
    J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro.
    Eriksson B; Courtier B; Bjŏrkman A; Miltgen F; Mazier D
    Trans R Soc Trop Med Hyg; 1991; 85(6):725-6. PubMed ID: 1801335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
    Nirmalan N; Sims PF; Hyde JE
    Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
    Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
    Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.